Pane humbowo hutsva hwekuti COVID-19 antibody inotapurira hutachiona hwekare inoderedza zvakanyanya njodzi yekutapukirwa zvakare mune ramangwana.
Ongororo yakaburitswa neChitatu mupepanhau reJAMA Internal Medicine yakawana kuti vanhu vakaongororwa vane hutachiona hweCCIDID-19 vaive nenjodzi yakadzikira yekutapukirwa nekoronavirus zvichienzaniswa nevaya vakaedza kuti masoja ekudzivirira chirwere haana.
Dr. Douglas Lowy vakati: “Miuyo yeiyi fundo yakaderedzwa zvikurukuru nechikamu chegumi, asi ndine mamwe mashoko pamusoro paikoku.Mune mamwe mazwi, izvi zvinogona kunge zviri kufungidzira kwekuderedzwa.Ichi chinogona kunge chiri chokwadi.Kusakoshesa kuderedzwa. "ndiye munyori wechidzidzo ichi uye mutevedzeri mukuru weNational Cancer Institute.
Iye akati: "Kwandiri, meseji huru-yakadzikiswa.""Chinonyanya kukosha ndechekuti masoja ekudzivirira chirwere mushure mekutapukirwa nehutachiona ane chekuita nekudzivirira kutapukirwa kutsva."
Lowy akawedzera kuti vanhu vakapora kubva kuCOVID-19 vanofanirwa kuramba vachibaiwa kana nguva yavo yasvika.
Vatsvagiri kubva kuNational Cancer Institute nemakambani akadai seLabCorp, Quest Diagnostics, Aetion Inc. uye HealthVerity vakadzidza dhata revanhu vanopfuura mamirioni mazana matatu nemazana maviri muUnited States vakapedza bvunzo dzeCCIDID-19 pakati paNdira naNyamavhuvhu gore rapfuura.Mune bvunzo idzi, 11.6% yeCCIDID-19 masoja ekudzivirira chirwere aive akanaka uye 88.3% aive asina kunaka.
Mune data rekutevera, vaongorori vakawana kuti mushure memazuva makumi mapfumbamwe, chete 0.3% yevanhu vakaedza hutachiona hweCCIDID-19 vakazoongororwa kuti vane hutachiona hwekoronavirus.Pakati pevarwere vane negative COVID-19 antibody bvunzo mhinduro, 3% vakazoonekwa vaine hutachiona hwekoronavirus panguva imwe cheteyo.
Pakazere, chidzidzo ichi chiri chekutarisa, uye chinoratidza mubatanidzwa pakati peiyo COVID-19 antibody bvunzo mhedzisiro uye njodzi yakaderedzwa yekutapukirwa mushure memazuva makumi mapfumbamwe-asi tsvakiridzo yakawanda inodiwa kuti uone causality uye kuti antibody inodzivirirwa kwenguva yakareba sei Pakupedzisira.
Roy akati kutsvagisa kwakawanda kunodiwa kuona njodzi yekutapukirwa zvakare yakakonzerwa neimwe yeachiri kubuda coronavirus akasiyana.
Lowe akati: “Zvino pane zvinonetsa izvi.Vanorevei?Mhinduro pfupi ndeyokuti hatizivi.”Akasimbisawo kuti vanhu vanovheneka kuti vane masoja ekudzivirira chirwere vanofanirwa kuramba vachibaiwa nhomba yeCOVID-19.
Zvinonyatsozivikanwa kuti varwere vazhinji vari kupora kubva kuCCIDID-19 vane masoja ekudzivirira chirwere, uye kusvika pari zvino, kuberekwazve kunoratidzika kunge kushoma-asi "dziviriro yeantibody ichagara kwenguva yakareba sei nekuda kwehutachiona hwechisikigo" haisati yanyatsojeka," Dr. Mitchell Katz weNYC Health + Chipatara chehutano hwehutano hwakanyora mupepeti yakatsikiswa pamwe chete netsvakiridzo itsva muJAMA Internal Medicine.
Katz akanyora kuti: "Saka, zvisinei nechimiro cheantibody, zvinokurudzirwa kuwana SARS-CoV-2 yekudzivirira."SARS-CoV-2 izita reiyo coronavirus inokonzera COVID-19.
Akanyora kuti: "Nguva yekudzivirirwa kweanorwisa majekiseni haizivikanwe.""Zvakakosha kuziva kuti dziviriro yemasoja ekudzivirira chirwere inotora nguva yakareba sei nekuda kwehutachiona hwepanyama kana kubaiwa.Nguva chete ndiyo ichataura.”
Hearst Terevhizheni inotora chikamu muzvirongwa zvakasiyana-siyana zvekushambadzira, izvo zvinoreva kuti tinogona kugamuchira makomisheni akabhadharwa ekutenga kuburikidza nezvinongedzo kune vatengesi mawebhusaiti.
Nguva yekutumira: Feb-25-2021